I just returned from Paris, where I visited Gillian Barratt, Juliette Vergnaud, and their group. Besides giving a talk on our work to find new therapies against acute myeloid leukaemia, we discussed further collaboration. We will host Félix Sauvage in October, and have planned a quite busy program for him. He will test liposome-encapsulated Hsp90 inhibitor on AML cells.
We will also send our PhD student Lene Myhren to Chatenay-Malabry to see if she can encapsulate a drug in nanoparticles, which will next be encapsulated in liposomes. Exciting! More information will follow later.
Faculté de Pharmacie, Chatenay Malabry, where Drs. Gillian Barratt and Juliette Vergnaud have their research labs.